Glucagon-like peptide-1 receptor / agonistsRefine your research by the most used items
Author / Editor
- Agoritsas, Thomas (1)
- Cartwright, Emma Jane (1)
- Ferns, Linda (1)
- Foroutan, Farid (1)
- Frere, Lawrie (1)
- Gariani, Karim (1)
- Gee, Patrick (1)
- Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC) (1)
- Guyatt, Gordon H (1)
- Hao, Qiukui (1)
Document type
Full text accessibility
Full text version
Subject
- Diabetes mellitus, type 2 / drug therapy (2)
- Humans (2)
- Blood glucose / metabolism (1)
- Cardiovascular diseases / prevention & control (1)
- Cost-benefit analysis (1)
- Developing countries (1)
- Diabete de type 2 (1)
- Diabetes mellitus, type 2 / epidemiology (1)
- Glp-1 (1)
- Glucagon-like peptide-1 receptor / therapeutic use (1)
Highlights
Show items per page
remove all| Title | Authors / Editors | Date | |
|---|---|---|---|
 |
Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis | Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC) | 2021 |
|
|
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline | Li, Sheyu; Vandvik, Per Olav; Lytvyn, Lyubov; Guyatt, Gordon H; ... Mustafa, Reem A | 2021 |
